And the government needs to intervene, requiring Medicare to treat obesity as a chronic condition and initiating coverage for Part D enrollees who are prescribed a GIP or GLP-1 medication solely for the treatment of weight loss, rather than restricting coverage to those with diabetes or cardiovascular disease
Proc Natl Acad Sci U S A 2011;108:8674-9
The FDA in early 2026 publicly highlighted enforcement actions targeting non-approved GLP-1 active ingredients in compounded products, so source verification is non-negotiable
Users should be cautioned that they arent a license to eat as much as you want and believe that the semaglutide will do all the work when it comes to healthful weight loss. Root, Leaf, and Hunger by Dana McCurdy, PhD In addition to the macronutrients (protein, complex carbohydrates, and lipids), probiotics, and even certain vitamins and minerals, a host of botanicals and mycoceuticals (bioactive fungi) long recognized via traditional practices have demonstrated effectiveness at increasing GLP-1 levels naturally
Third-party tested active charcoal provides purity, potency & safety, giving effective support for sleep, relaxation & cognitive health.